Eugene W. Shek

1.9k total citations · 1 hit paper
18 papers, 1.6k citations indexed

About

Eugene W. Shek is a scholar working on Endocrine and Autonomic Systems, Epidemiology and Physiology. According to data from OpenAlex, Eugene W. Shek has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrine and Autonomic Systems, 8 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Eugene W. Shek's work include Regulation of Appetite and Obesity (9 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Eugene W. Shek is often cited by papers focused on Regulation of Appetite and Obesity (9 papers), Adipokines, Inflammation, and Metabolic Diseases (8 papers) and Biochemical Analysis and Sensing Techniques (6 papers). Eugene W. Shek collaborates with scholars based in United States. Eugene W. Shek's co-authors include John E. Hall, Michael W. Brands, Philip J. Scarpace, Michael E. Matheny, Sergei Zolotukhin, Victor Prima, Jeffrey R. Henegar, George Aslanidi, Martha Campbell‐Thompson and Stanislav Shklyaev and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Endocrinology.

In The Last Decade

Eugene W. Shek

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic Leptin Infusion Increases Arterial Pressure

1998 581 citations Eugene W. Shek, Michael W. Brands et al. Hypertension profile →

Peers

Countries citing papers authored by Eugene W. Shek

Since Specialization

Citations

This map shows the geographic impact of Eugene W. Shek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene W. Shek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene W. Shek more than expected).

Fields of papers citing papers by Eugene W. Shek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene W. Shek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene W. Shek. The network helps show where Eugene W. Shek may publish in the future.

Co-authorship network of co-authors of Eugene W. Shek

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene W. Shek. A scholar is included among the top collaborators of Eugene W. Shek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene W. Shek. Eugene W. Shek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure models 2012 ·Journal of Pathology Informatics ·(unknown), Gerard D. Gagné, Sherry J. Morgan, (unknown), Bruce E. LeRoy, Eric A.G. Blomme, Bryan F. Cox, Eugene W. Shek	28
2	The proconvulsant effects of leptin on glutamate receptor-mediated seizures in mice 2010 ·Brain Research Bulletin ·James J. Lynch, Eugene W. Shek, Vincent Castagné, Scott W. Mittelstadt	20
3	Neutralization of tumor necrosis factor-α reverses insulin resistance in skeletal muscle but not adipose tissue 2004 ·American Journal of Physiology-Endocrinology and Metabolism ·Stephen E. Borst, Youngil Lee, Christine F. Conover, Eugene W. Shek, Gregory J. Bagby	35
4	Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats 2003 ·Proceedings of the National Academy of Sciences ·Stanislav Shklyaev, George Aslanidi, (unknown), Victor Prima, (unknown), (unknown), Martha Campbell‐Thompson, James M. Crawford, Eugene W. Shek, Philip J. Scarpace, Sergei Zolotukhin	206
5	Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses 2002 ·Gene Therapy ·Jared Wilsey, Sergei Zolotukhin, Victor Prima, Eugene W. Shek, Michael K. Matheny, Philip J. Scarpace	17
6	Central leptin gene delivery evokes persistent leptin signal transduction in young and aged-obese rats but physiological responses become attenuated over time in aged-obese rats 2002 ·Neuropharmacology ·Philip J. Scarpace, Michael E. Matheny, (unknown), Nihal Tümer, (unknown), Eugene W. Shek, Bum‐Kee Hong, Victor Prima, Sergei Zolotukhin	59
7	Leptin-Induced Leptin Resistance Reveals Separate Roles for the Anorexic and Thermogenic Responses in Weight Maintenance 2002 ·Endocrinology ·Philip J. Scarpace, Michael E. Matheny, (unknown), Eugene W. Shek, Victor Prima, Sergei Zolotukhin, Nihal Tümer	57
8	Resistance to the anorexic and thermogenic effects of centrally administrated leptin in obese aged rats 2000 ·Regulatory Peptides ·Eugene W. Shek, Philip J. Scarpace	76
9	Impaired leptin signal transduction with age-related obesity 2000 ·Neuropharmacology ·Philip J. Scarpace, Michael E. Matheny, Eugene W. Shek	93
10	Hyperhomocyst(e)inemia induces multiorgan damage 2000 ·Heart and Vessels ·Amanda J. Miller, Vibhas S. Mujumdar, Eugene W. Shek, (unknown), Michael Angelo, Lena Palmér, Suresh C. Tyagi	74
11	Does leptin contribute to obesity hypertension? 1999 ·Current Opinion in Endocrinology & Diabetes ·John E. Hall, Eugene W. Shek, Michael W. Brands	5
12	ABNORMAL KIDNEY FUNCTION AS A CAUSE AND A CONSEQUENCE OF OBESITY HYPERTENSION 1998 ·Clinical and Experimental Pharmacology and Physiology ·John E. Hall, Michael W. Brands, Jeffrey R. Henegar, Eugene W. Shek	83
13	Sodium Induces Hypertrophy of Cultured Myocardial Myoblasts and Vascular Smooth Muscle Cells 1998 ·Hypertension ·Jianwei Gu, (unknown), Eugene W. Shek, Michael C. Moore, (unknown), (unknown), Thomas H. Adair	121
14	Chronic Leptin Infusion Increases Arterial Pressure breakdown → 1998 ·Hypertension ·Eugene W. Shek, Michael W. Brands, John E. Hall	581
15	Insulin-Induced Hypertension in Rats Depends on an Intact Renin-Angiotensin System 1997 ·Hypertension ·Michael W. Brands, David L. Harrison, Henry L. Keen, (unknown), Eugene W. Shek, John E. Hall	53
16	Thromboxane Is Required for Full Expression of Angiotensin Hypertension in Rats 1997 ·Hypertension ·Henry L. Keen, Michael Brands, M. J. Smith, Eugene W. Shek, John E. Hall	30
17	Central role of the kidney and abnormal fluid volume control in hypertension. 1996 ·PubMed ·John E. Hall, Michael W. Brands, Eugene W. Shek	40
18	Effects of ATP-sensitive K+-channel activators on transmitter release parameters at the frog neuromuscular junction 1993 ·Brain Research ·(unknown), Eugene W. Shek, Karim A. Alkadhi	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact